|
Headlines:
|
 |
Back to Gynecology Articles
Wednesday January 16, 2003 10:25 PM GMT
|
[gynecology/articles/abortion/mifepruse/includes/toolbar_rt.htm] |
Study published by the Alan Guttmacher Institute shows a growing tendency
towards the use of the abortion pill accompanied by a parallel decrease surgical
abortion.
Mifepristone, or the abortion pill (Mifeprex®) as it is known, was approved
by FDA in September 2000 as an option for first-trimester abortions. The drug can be used up to seven weeks after the beginning of a woman's last
menstrual period.
In all, more than 130,000 women in the United States have used the pill to
obtain abortions since its approval. The research appears in the January/February issue of the Perspectives on
Sexual and Reproductive Health journal.
Mifepristone acts by binding to the progesterone receptors in the uterus.
This leads to contraction of the uterus causing abortion of the fetus.
In April last year Danco Laboratories issued a letter to health care
providers following several cases of ruptured ectopic pregnancy. The letter was
to remind health care providers that Mifepristone was not to be used in ectopic
pregnancy.
It has also been reported that there is a risk of serious systemic infection.
The rate of serious infection as a complication of pregnancy is 3.5 per 1000
pregnancies. Uterine infection occurs in 0.1-4.7% of first trimester surgical
abortions and in 0.0-6.1% of medical abortions. In the past, it was most often
associated with illegal abortions. It rarely occurs with pelvic surgery or even
with otherwise normal childbirth.
A single heart attack occurred in a 21-year old. This is the only case of
heart attack reported with Mifeprex and misoprostol use.

|
|
|
|
Are you a doctor or a nurse?
Do you want to join the Doctors Lounge online medical community?
Participate in editorial activities (publish, peer review, edit) and
give a helping hand to the largest online community of patients.
Click on the link below to see the requirements:
Doctors Lounge Membership
Application |
|
|